List of insiders holdings for AGIOS PHARMACEUTICALS Inc:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
CELGENE CORP
Celgene European Investment Co LLC
Celgene Switzerland LLC
Celgene Alpine Investment Co. LLC
10% Owner
2019-11-14 16:07:117,121,658
0
7,121,658Form 13D
STARR KEVIN P
Director
10% Owner
2015-02-19 19:01:33342,253
4,590,480
4,932,733Form 4
THIRD ROCK VENTURES LP
Third Rock Ventures GP L.P.
TRV GP LLC
10% Owner
2015-02-19 19:03:374,590,480
0
4,590,480Form 4
Flagship Ventures Fund 2007 L.P.
AFEYAN NOUBAR
KANIA EDWIN M JR
Flagship Ventures 2007 General Partner LLC
10% Owner
2017-02-13 14:25:03965,369
0
965,369Form 13G
Schenkein David P
Director
2023-01-19 16:03:43234,242
349,854
584,096Form 4
Mak Tak W.
10% Owner
2013-07-23 20:23:06545,454
0
545,454Form 3
Higgons John Duncan
Chief Operating Officer
2016-01-05 17:20:30483,035
0
483,035Form 4
FOUSE JACQUALYN A
Chief Executive Officer
2022-04-12 16:01:36217,800
0
217,800Form 4
Cantley Lewis Clayton Jr.
Director
2017-12-08 16:23:4279,475
121,121
200,596Form 4
Milanova Tsveta
Chief Commercial Officer
2023-01-05 16:11:00161,108
0
161,108Form 4
Jones Cecilia
Chief Financial Officer
2022-09-28 16:10:56140,807
0
140,807Form 4
Hoerter Steven L.
Chief Commercial Officer
2019-03-05 16:04:05117,241
0
117,241Form 4
NELSEN ROBERT
Director
2017-03-07 16:35:15109,230
0
109,230Form 4
Goddard Glenn
Senior Vice President Finance
2016-02-18 17:15:42108,572
0
108,572Form 4
Biller Scott
Chief Scientific Officer
2019-06-13 16:07:4233,729
53,059
86,788Form 4
Biller Jonathan
Chief Financial Officer
2022-03-03 16:12:1952,500
0
52,500Form 4
Car Bruce
Chief Scientific Officer
2022-03-03 16:11:4652,500
0
52,500Form 4
Tessier-Lavigne Marc
Director
2016-06-23 16:10:1848,875
0
48,875Form 4
Smith Cynthia
Director
2022-08-15 18:44:2644,853
0
44,853Form 4
Ballal Rahul D.
Director
2022-08-15 18:31:2344,853
0
44,853Form 4
Hirsch Andrew
Chief Financial Officer
2020-04-24 16:06:3636,057
0
36,057Form 4
Scadden David
Director
2022-06-23 16:11:3834,282
0
34,282Form 4
MARAGANORE JOHN
Director
2022-06-23 16:11:1434,282
0
34,282Form 4
Clancy Paul J
Director
2022-06-23 16:09:4034,282
0
34,282Form 4
Ho Maykin
Director
2022-06-23 16:10:2534,282
0
34,282Form 4
KARSEN PERRY A
Director
2015-06-25 18:26:5323,125
0
23,125Form 4
Burns James William
Chief Legal Officer
2022-12-28 16:05:2421,218
0
21,218Form 4
Bowden Christopher
Chief Medical Officer
2021-06-22 16:44:1916,479
0
16,479Form 4
Gheuens Sarah
Chief Medical Officer
2022-12-28 16:05:0415,605
0
15,605Form 4
Foster-Cheek Kaye I
Director
2023-01-18 16:09:106549
2200
8749Form 4
Poddar Richa
Chief Commercial Officer
2022-10-18 16:17:108508
0
8508Form 4
Miles Darrin
Chief Commercial Officer
2021-05-18 16:11:407209
0
7209Form 4
CLARK IAN T
Director
2022-05-24 16:12:106549
0
6549Form 4
Cole Douglas G.
Director
2016-08-11 16:33:473695
0
3695Form 4
Alenson Carman
Principal Accounting Officer
2021-06-23 17:28:443555
0
3555Form 4
Washburn Theodore James Jr.
Principal Accounting Officer
2022-03-03 16:10:203496
0
3496Form 4
Goff Brian
Chief Executive Officer
2022-08-09 17:08:410
0
0Form 3/A
Arch Venture Fund VII LP
ARCH Venture Partners VII L.P.
ARCH Venture Partners VII LLC
CRANDELL KEITH
BYBEE CLINTON
10% Owner
2016-02-11 12:24:080
0
0Form 13G